tiprankstipranks
Vistagen secures additional patent protection for PH94B
The Fly

Vistagen secures additional patent protection for PH94B

Vistagen announced that the company has taken important strategic steps to secure additional patent protection for its lead product candidate, PH94B, through the recent filing of national applications at the U.S. Patent and Trademark Office, or USPTO, and counterpart patent authorities in major pharmaceutical markets outside the U.S. for the treatment of adjustment disorder, or AjD. These new filings are intended to provide a global exclusivity platform for PH94B in AjD, similar to the Company’s patent protection for PH94B for the treatment of social anxiety disorder, and for its other late-clinical stage product candidate, PH10, for the treatment of major depressive disorder.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on VTGN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles